AMY FORREST: Open Payments
NPI 1184199101 · GREENVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,631 in 193 payments from 23 companies in 2025. Trend: 2023 $303 · 2024 $2,036 · 2025 $3,631
Food & beverage: $3,631
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 37 | $595 |
| Takeda Pharmaceuticals U.S.A., Inc. | 30 | $525 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 20 | $481 |
| Janssen Biotech, Inc. | 12 | $234 |
| Ardelyx, Inc. | 14 | $226 |
| QOL Medical, LLC | 11 | $216 |
| Madrigal Pharmaceuticals | 3 | $184 |
| Aimmune Therapeutics, Inc. | 8 | $176 |
| PFIZER INC. | 19 | $162 |
| GENZYME CORPORATION | 5 | $143 |
Products named: XIFAXAN, ENTYVIO, RINVOQ, DUPIXENT, TREMFYA, IBSRELA, Sucraid, REZDIFFRA.
Industry payments across NC — which companies pay providers there.
